Chemotherapy Omission in HR-positive/HER2-negative Breast Cancer With Lymph Node Negative Disease Receiving Adjuvant Endocrine Therapy and CDK4/6 Inhibitor
PHASE3
This is a prospective, randomized, open-label, multicenter phase III study ...
Testing Whether Hormone Therapy With Ribociclib is as Effective as Chemotherapy Followed by Hormone Therapy With Ribociclib for the Treatment of High Anatomic Stage Breast Cancer With Low Recurrence Risk, The RxFINE-Low Trial
PHASE3
This phase III trial compares standard of care hormone therapy plus ribocic...
Status
Recruiting
Location
NEA Baptist Memorial Hospital and Fowler Family Cancer Center - Jonesboro
First-Line Ribociclib Plus Endocrine Therapy Versus Chemotherapy With or Without Subsequent Endocrine Therapy in Patients With Rapidly Progressive HR-Positive/HER2-Negative Advanced Breast Cancer
PHASE2
This phase II study focuses on women with rapidly progressive hormone recep...
Study to Compare the Combination of Ribociclib Plus Goserelin Acetate With Hormonal Therapy Versus Combination Chemotherapy in Premenopausal or Perimenopausal Patients With Advanced or Metastatic Breast Cancer
PHASE2
To compare the combination of Ribociclib plus goserelin acetate with hormon...